H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)

May 26, 2026 6:58 AM

H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $25.00 price target on Voyager Therapeutics (NASDAQ: VYGR).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found